| Michael S Travisano, DPM | |
|
364 E Main St, Ansonia, CT 06401-1904 | |
| (203) 734-4806 | |
| (203) 734-8265 |
| Full Name | Michael S Travisano |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 29 Years |
| Location | 364 E Main St, Ansonia, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801807953 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | 000678 (Connecticut) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ansonia Podiatry Associates, Llc | 1850466160 | 2 |
News Archive
Finding creative ways to recruit and retain nurses at a Reno, Nevada, hospital led Barbara Hobbs, assistant dean of the SDSU College of Nursing Rapid City Site, to pursue research on the impact of shift work.
NeuroSigma, Inc., a Los Angeles-based medical device company, today announced it has been awarded a Phase I NIH-STTR grant from the National Institute of Neurological Disorders and Stroke (NINDS) for the further development of its Thin-Film Nitinol (TFN)-covered stent for the potential treatment of brain aneurysms.
University of Granada researchers have tested melatonin analogues in rats as it inhibits the enzyme nitric oxide synthase (NOS), which is involved in the development of conditions as inflammatory bowel disease, septic shock or rheumatoid arthritis, as well as in neurodegenerative conditions as Huntington's disease, Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis.
Nitric oxide (NO) prevents high blood pressure and artery plaque build-up in our body. However, its duplicity is shown when it causes serious inflammatory disease such as systemic lupus erythematosus, Cronh's disease, and rheumatoid arthritis.
NicOx S.A. has announced it has signed an agreement with DSM for the commercial manufacture and supply of naproxcinod drug substance (or API, active pharmaceutical ingredient).
› Verified 8 days ago
| Provider Name | Ansonia Podiatry Associates, Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1689841520 PECOS PAC ID: 1850466160 Enrollment ID: O20080821000302 |
News Archive
Finding creative ways to recruit and retain nurses at a Reno, Nevada, hospital led Barbara Hobbs, assistant dean of the SDSU College of Nursing Rapid City Site, to pursue research on the impact of shift work.
NeuroSigma, Inc., a Los Angeles-based medical device company, today announced it has been awarded a Phase I NIH-STTR grant from the National Institute of Neurological Disorders and Stroke (NINDS) for the further development of its Thin-Film Nitinol (TFN)-covered stent for the potential treatment of brain aneurysms.
University of Granada researchers have tested melatonin analogues in rats as it inhibits the enzyme nitric oxide synthase (NOS), which is involved in the development of conditions as inflammatory bowel disease, septic shock or rheumatoid arthritis, as well as in neurodegenerative conditions as Huntington's disease, Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis.
Nitric oxide (NO) prevents high blood pressure and artery plaque build-up in our body. However, its duplicity is shown when it causes serious inflammatory disease such as systemic lupus erythematosus, Cronh's disease, and rheumatoid arthritis.
NicOx S.A. has announced it has signed an agreement with DSM for the commercial manufacture and supply of naproxcinod drug substance (or API, active pharmaceutical ingredient).
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael S Travisano, DPM 364 E Main St, Ansonia, CT 06401-1904 Ph: (203) 734-4806 | Michael S Travisano, DPM 364 E Main St, Ansonia, CT 06401-1904 Ph: (203) 734-4806 |
News Archive
Finding creative ways to recruit and retain nurses at a Reno, Nevada, hospital led Barbara Hobbs, assistant dean of the SDSU College of Nursing Rapid City Site, to pursue research on the impact of shift work.
NeuroSigma, Inc., a Los Angeles-based medical device company, today announced it has been awarded a Phase I NIH-STTR grant from the National Institute of Neurological Disorders and Stroke (NINDS) for the further development of its Thin-Film Nitinol (TFN)-covered stent for the potential treatment of brain aneurysms.
University of Granada researchers have tested melatonin analogues in rats as it inhibits the enzyme nitric oxide synthase (NOS), which is involved in the development of conditions as inflammatory bowel disease, septic shock or rheumatoid arthritis, as well as in neurodegenerative conditions as Huntington's disease, Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis.
Nitric oxide (NO) prevents high blood pressure and artery plaque build-up in our body. However, its duplicity is shown when it causes serious inflammatory disease such as systemic lupus erythematosus, Cronh's disease, and rheumatoid arthritis.
NicOx S.A. has announced it has signed an agreement with DSM for the commercial manufacture and supply of naproxcinod drug substance (or API, active pharmaceutical ingredient).
› Verified 8 days ago
Yale Podiatry Group Pc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 364 E Main St, Yale Podiatry Group Pc, Ansonia, CT 06401 Phone: 203-734-4806 Fax: 203-734-8265 | |
Yale Podiatry Group Podiatrist Medicare: Medicare Enrolled Practice Location: 364 E Main St, Ansonia, CT 06401 Phone: 203-734-4806 Fax: 203-734-8265 | |
Jeffrey F Yale, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 364 E Main St, Ansonia, CT 06401 Phone: 203-734-4806 Fax: 203-734-8265 | |
Mithun Sivadasan, Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 364 E Main St, Ansonia, CT 06401 Phone: 203-734-4806 |